|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| Gross written premiums | |||||
| Less: premiums ceded to reinsurers | |||||
| Net written premiums | |||||
| Net change in unearned premium reserves | |||||
| Net premiums earned | |||||
| Investment income | |||||
| Net realised gains on financial assets | |||||
| Net fair value gains through profit or loss | |||||
| Other income | |||||
| Total revenues | |||||
| BENEFITS, CLAIMS AND EXPENSES | |||||
| Insurance benefits and claims expenses - Life insurance death and other benefits | |||||
| Insurance benefits and claims expenses - Accident and health claims and claim adjustment expenses | |||||
| Insurance benefits and claims expenses - Increase in insurance contract liabilities | |||||
| Investment contract benefits | |||||
| Policyholder dividends resulting from participation in profits | |||||
| Underwriting and policy acquisition costs | |||||
| Finance costs | |||||
| Administrative expenses | |||||
| Statutory insurance fund contribution | |||||
| Other expenses | |||||
| Total benefits, claims and expenses | |||||
| Net gains on investments of associates and joint ventures (Including: share of profit of associates and joint ventures of RMB3,628 million, 10,328 million, 8,336 million for 2022, 2021 and 2020) | |||||
| Including: share of profit of associates and joint ventures | |||||
| Profit before income tax | |||||
| Income tax | |||||
| Net profit | |||||
| Attributable to: | |||||
| Equity holders of the Company | |||||
| Non-controlling interests | |||||
| Basic and diluted earnings per share | |||||
| Other comprehensive income that may be reclassified to profit or loss in subsequent periods: | |||||
| Fair value gains/(losses) on available-for-sale securities | |||||
| Amount transferred to net profit from other comprehensive income | |||||
| Portion of fair value changes on available-for-sale securities attributable to policyholders equity | |||||
| Share of other comprehensive income of associates and joint ventures under the equity method | |||||
| Exchange differences on translating foreign operations | |||||
| Income tax relating to components of other comprehensive income | |||||
| Other comprehensive income that may be reclassified to profit or loss in subsequent periods | |||||
| Other comprehensive income that will not be reclassified to profit or loss in subsequent periods: | |||||
| Share of other comprehensive income of associates and joint ventures under the equity method | |||||
| Other comprehensive income for the year, net of tax | |||||
| Total comprehensive income for the year, net of tax | |||||
Loading...